AzTrials
AzTrials

Autism Spectrum DisordersBSLNCT02700074

Brain Mechanisms for Language Processing in Adolescents With Autism Spectrum Disorder

An observational study of Autism Spectrum Disorders, run by Boston University Charles River Campus at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main goal of our study is to find out why some people with Autism Spectrum Disorder (ASD) do not develop verbal abilities or remain minimally-verbal throughout adolescence and adulthood. Read more about this study

Who is it for?
Ages 14 to 21 yearsHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorders
How many people
88 participants
Where
1 siteUnited States
Study dates
Feb 2015to 30 Aug 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 21 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: Community sample

Who may be able to join

  • Between the ages of 14 and 21
  • Minimally verbal (which is defined as having fewer than 10 words/phrases used communicatively during the Autism Diagnostic Observation Schedule (ADOS) assessment
  • Demonstrated minimal progress in speech acquisition despite having participated in speech therapy for at least 18 months
  • Diagnosis of Autism Spectrum Disorder (ASD)
  • Verbal but language impaired (defined as more than 1.25 standard deviation below the mean on the clinical evaluation of language fundamentals - Fourth edition (CELF-4))
  • Has normal language scores (on the CELF-4)
  • Is typically developing with no history of psychiatric or neurological disorders

Who cannot join

  • Has contraindications to having a magnetic resonance imaging (MRI) scan (e.g. electronic/ferromagnetic implant, clips, stents, existing or planned major dental work)
  • Has a history of significant neurological diseases
  • Has a history of sensory impairment (e.g., hearing impairment)
  • Has a history of disorders other than ASD
  • Is currently taking antipsychotic medications.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Boston University

    Boston, Massachusetts, 02215

Other trials in United States

About this study

Official title: ACE (Autism Center of Excellence): Brain Mechanisms for Language Processing in Adolescents With Autism Spectrum Disorder

The main goal of our study is to find out why some people with Autism Spectrum Disorder (ASD) do not develop verbal abilities or remain minimally-verbal throughout adolescence and adulthood. Current research focuses on investigating brain differences related to processing sounds and initiating speech in adolescents and young adults with ASD varying in language skills, compared to adolescents who do not have ASD, in order to clarify whether atypical processes of auditory perception, perceptual organization and/or neural oscillation patterns may explain why some individuals with ASD fail to acquire functional speech.

Read the detailed description

About 30% of children with Autism Spectrum Disorder (ASD) fail to acquire spoken language. This group of children has been seriously neglected in research conducted over the past 2 decades. Little is known about them, in part because the field lacks the tools to assess them, and they often pose significant behavioral challenges that preclude their participation in research studies. Among the ~70% individuals with ASD who have spoken language skills, about 50% are language impaired; the remaining group have normal language scores on standardized tests. Thus, there is enormous heterogeneity in verbal abilities in ASD. To date, studies of the brain and cognitive mechanisms that underlie this heterogeneity remain quite limited.

At the cognitive level, current research suggests that language impairment in verbal children with ASD involves deficits in phonological working memory, as evident on tests of nonsense word repetition. The areas of language that are most affected in this group include complex syntax and morphology related to marking tense (Tager-Flusberg et al., 2005). There is also considerable evidence from MRI (magnetic resonance imaging) studies of both children and adults that there are differences in volume and asymmetry in language regions of the cortex, specifically Broca's and Wernicke's areas. Recent studies suggest that these differences do not necessarily track with degree of language impairment, though there are conflicting findings in the literature. Importantly, most of the participants in cognitive and neuroimaging studies of ASD have been adults and individuals who have relatively intact language. Far less is known about the processes (either cognitive or neural) that might be implicated in the minimally verbal group. This project is designed to address this issue using two different brain imaging methods and approaches.

  1. fMRI and DTI: Converging lines of evidence support the view that ASDs are disorders of connectivity, in which abnormalities in white matter integrity and reduced coordination of activity across brain regions give rise to core features. Recent results from our group (Guenther; Manoach) have identified white matter anomalies in the speech network of high-functioning verbal adults with ASD, specifically in the pathway between the left supplementary motor area (SMA) and left ventral premotor cortex (vPMC), a pathway involved in the initiation of speech output according to the Directions into Velocities of Articulators (DIVA) model of speech production, a leading model of the neural computations underlying speech. These connectivity abnormalities are revealed in both DTI and functional connectivity analyses collected using fMRI. NOTE: IRB approval for the collection of fMRI/DTI data will be obtained from MGH, where this portion of the study will be carried out. Data analyses will be carried out at MGH and BU.
  2. Electrophysiology: EEG/ERP It has long been known that some children with ASD fail to respond when spoken to, cover their ears in the presence of certain sounds, yet show highly acute hearing in other contexts. Little is known about the mechanisms that might underlie these unusual auditory processing profiles. Abnormal neural oscillations have been found to be an endophenotype for ASD in infants and adults. However, the picture of how oscillations differ from those of non-clinical subjects is unclear and depends on the age at testing. Characterizing the oscillations present in the brains of a range of adolescents will allow us to quantify the relationship between neural activity and severity of language impairment. The main hypothesis that will be tested in this project is that abnormal neural connectivity in minimally verbal children with ASD profoundly impedes the ability to perceptually organize auditory scenes into meaningful units or objects, which has a direct effect on language development in these individuals. Event-related brain potentials (ERPs) and frequency-based analysis of the electroencephalogram (EEG) will be collected during passive listening tasks, to evaluate auditory perception and the perceptual organization of tones and speech using the mismatch negativity (MMN) paradigm (the MMN reflects passive deviance detection processes indexing low-level acoustic processes in automatic sensory memory mechanisms, and it has been widely investigated in studies of auditory perceptual discrimination of tones and speech).

The investigators plan to collect these data from 3 groups of adolescents with ASD varying in language skills (minimally verbal, verbal-language impaired, verbal-language normal) and age and gender matched non-ASD typical adolescents. The participants will be diagnosed and tested using a range of standardized and non-standardized assessments including IQ/cognitive level; social abilities; ASD severity; communication skills (nonverbal). These assessments will be carried out by trained examiners in the clinical core housed at BU.

Because many of the participants present with highly challenging behaviors and are difficult to test, a number of innovative approaches will be taken to maximize participants' success in completing the behavioral assessments, and then to tolerate and provide artifact-free data in the electrophysiological and MRI portions of the study.

Overall, the investigators hypothesize that the groups tested will differ in their neural indices of auditory perception, neural indices of perceptual organization, and induced neural oscillations. Further, the investigators hypothesize that differences in the degree of language impairment across these groups will be correlated with differences in the degree of abnormality of the measured neural indices, but not in the form of the abnormality, suggesting that the root causes of the differences across the tested subject groups are quantitative rather than qualitative.

Being tested
No Intervention
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No InterventionOther

    Intervention is not a part of this study.

Study groups in NCT02700074
Study groupRoleWhat they receive
Minimally VerbalMinimally verbal adolescents with Autism Spectrum Disorder
Receives: Other: No Intervention
Verbal ImpairedLanguage impaired adolescents with ASD
Receives: Other: No Intervention
Verbal NormalLanguage normal adolescents with ASD
Receives: Other: No Intervention
Typically DevelopingTypically developing adolescent controls
Receives: Other: No Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Autism Spectrum Diagnosis

    Interview

    Measured: 5 years

  2. Adaptive Behaviors

    Interview

    Measured: 5 years

  3. Cognitive Abilities

    Interview

    Measured: 5 years

  4. Language Abilities

    Interview and Questionnaire

    Measured: 5 years

  5. Social Behavior

    Interview

    Measured: 5 years

  6. Repetitive Behavior

    Questionnaire

    Measured: 5 years

  7. Sensory Behavior

    Questionnaire

    Measured: 5 years

  8. Atypical Behavior

    Questionnaire

    Measured: 5 years

  9. Psychopathology

    Questionnaire

    Measured: 5 years

  10. Emotion Regulation

    Questionnaire

    Measured: 5 years

  11. Handedness

    Questionnaire

    Measured: 5 years

  12. Brain measures of structural and functional connectivity in key nodes of the speech production network

    In particular between the supplementary motor area (SMA) and ventral premotor cortex (vPMC), a set of nodes in the speech network that is critical for the initiation of speech motor programs. High resolution MRI brain scans collected from adolescents with ASD who vary in their language ability from minimally verbal to normal (and a typical control group). Measures of structural anatomical connectivity based on Diffusion Tensor Imaging (DTI) data and functional connectivity based on resting state functional connectivity MRI.

    Measured: 5 years

  13. Electrophysiological measures and neural oscillatory patterns of the perception, organization and analysis of auditory scenes.

    Physiological parameter

    Measured: 5 years

  14. Indices of social attention deployment measured by unobtrusively recording participants' eye-movements during the passive viewing of brief realistic video-clips.

    Physiological parameter

    Measured: 5 years

  15. Indices of electrodermal activity (EDA) measured wirelessly with the Q sensor (a small wearable device designed to work in real-world environments in an untethered, unobtrusive way).

    Physiological parameter

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2016 (estimated)
  2. Study startFeb 2015
  3. Primary completion31 May 2019
  4. Study completion30 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
88 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02700074
Sponsor's protocol ID
3077E
Other IDs
P50DC013027
Acronym
BSL
Status last verified
Jan 2020
First submitted
24 Feb 2016
Last updated
27 Jan 2020
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Tager-Flusberg H, Kasari C. Minimally verbal school-aged children with autism spectrum disorder: the neglected end of the spectrum. Autism Res. 2013 Dec;6(6):468-78. doi: 10.1002/aur.1329. Epub 2013 Oct 7.

    PubMed 24124067

Questions about this trial

What is this clinical trial studying?

An observational study of Autism Spectrum Disorders, run by Boston University Charles River Campus at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Autism Spectrum Diagnosis (time frame: 5 years). The study lists 15 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02700074, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in